Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell carcinoma.
Dr. Alan Tan
Advertisement
Dr. Alan Tan is a GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Naashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer at the Alliance for Clinical Trials in Oncology.
Articles by Dr. Alan Tan
Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ctDNA.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
